Dr. Marchand joined Certara (formerly Pharsight Corporation) in September of 2010. Dr. Marchand is a PharmD by trade and obtained her PhD in Pharmacometrics at the University of Marseille in 2007. Her PhD project called Model-based Drug Development: Examples in Epilepsy, was a collaboration between the University of Marseille and a Pharmaceutical company. Prior to joining in 2010, Mathilde was consultant in Pharmacometrics at EMF consulting, working with Eliane Fuseau. Her work focused on population PK/PD and exposure-response modeling in the area of CNS diseases such as epilepsy, Parkinson’s disease and clinical trial simulation for the optimization of pediatric dose.
At Certara, she is currently working as Associate Director, on various types of modeling and simulation projects, especially in oncology.